RET polymorphisms and sporadic medullary thyroid carcinoma in a Portuguese population

被引:22
作者
Costa, P
Domingues, R
Sobrinho, LG
Bugalho, MJ [1 ]
机构
[1] Ctr Reg Oncol Lisboa, Serv Endocrinol, Inst Portugues Oncol Francisco Gentil, P-1099023 Lisbon, Portugal
[2] Ctr Reg Oncol Lisboa, Ctr Invest Patobiol Mol, P-1099023 Lisbon, Portugal
关键词
cancer susceptibility; MTC; polymorphisms; RET; meta-analysis;
D O I
10.1385/ENDO:27:3:239
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The genetic basis of the sporadic form of medullary thyroid carcinoma, derived from "C" cells, is still poorly understood. Somatic mutations of RET proto-oncogene have been reported at a variable frequency ranging from 23% to 69%. The hypothesis that low penetrance factors, such as polymorphisms, might contribute to the phenotype of this neoplasm has been addressed in a few studies conducting to conflicting results. Herein, we studied 100 individuals (50 patients and 50 controls) aiming to compare the frequencies of G691S, L769L, S836S, and S904S RET polymorphisms observed in patients with respect to controls. Furthermore, meta-analysis of published studies including the present results was conducted. To test the contributory role of the above polymorphisms for the development of "C"-cell hyperplasia, we studied a group of 10 individuals selected for having a positive pentagastrin test despite the absence of a RET germline mutation. An over-representation of the G691S polymorphism, particularly in females, was observed in patients with respect to controls, although not reaching the level of significance. Allelic frequencies of the other three polymorphisms were not different in patients and controls. Results obtained in the admittedly small group of individuals with a positive pentagastrin test are unlikely to support a major influence of any polymorphism in the development of "C"-cell hyperplasia. The meta-analysis provided evidence for a significant association of the S691 allele with MTC (odds ratio 1.54, 95% confidence interval 1.12-2.12, p = 0.008) and found no significant associations for the other polymorphisms.
引用
收藏
页码:239 / 243
页数:5
相关论文
共 41 条
[1]   Germline-sequence variants S836S and L769L in the RE arranged during Transfection (RET) proto-oncogene are not associated with predisposition to sporadic medullary carcinoma in the French population [J].
Berard, I ;
Kraimps, JL ;
Savagner, F ;
Murat, A ;
Renaudin, K ;
Nicolli-Sire, P ;
Bertrand, G ;
Moisan, JP ;
Bezieau, S .
CLINICAL GENETICS, 2004, 65 (02) :150-152
[2]   RET PROTOONCOGENE MUTATIONS IN INHERITED AND SPORADIC MEDULLARY-THYROID CANCER [J].
BLAUGRUND, JE ;
JOHNS, MM ;
EBY, YJ ;
BALL, DW ;
BAYLIN, SB ;
HRUBAN, RH ;
SIDRANSKY, D .
HUMAN MOLECULAR GENETICS, 1994, 3 (10) :1895-1897
[3]   Specific polymorphisms in the RET proto-oncogene are over-represented in patients with Hirschsprung disease and may represent loci modifying phenotypic expression [J].
Borrego, S ;
Sáez, ME ;
Ruiz, A ;
Gimm, O ;
López-Alonso, M ;
Antiñolo, G ;
Eng, C .
JOURNAL OF MEDICAL GENETICS, 1999, 36 (10) :771-774
[4]   RET genotypes comprising specific haplotypes of polymorphic variants predispose to isolated Hirschsprung disease [J].
Borrego, S ;
Ruiz, A ;
Saez, ME ;
Gimm, O ;
Gao, X ;
López-Alonso, M ;
Hernández, A ;
Wright, FA ;
Antiñolo, G ;
Eng, C .
JOURNAL OF MEDICAL GENETICS, 2000, 37 (08) :572-578
[5]   RAPID ISOLATION OF EUKARYOTIC DNA [J].
BOWTELL, DDL .
ANALYTICAL BIOCHEMISTRY, 1987, 162 (02) :463-465
[6]   Molecular analysis of the RET proto-oncogene in patients with sporadic medullary thyroid carcinoma: A novel point mutation in the extracellular cysteine-rich domain [J].
Bugalho, MJ ;
Frade, JP ;
Santos, JR ;
Limbert, E ;
Sobrinho, L .
EUROPEAN JOURNAL OF ENDOCRINOLOGY, 1997, 136 (04) :423-426
[7]   IDENTIFICATION OF A POLYMORPHISM IN EXON-11 OF THE RET PROTOONCOGENE [J].
BUGALHO, MJM ;
COTE, GJ ;
KHORANA, S ;
SCHULTZ, PN ;
GAGEL, RF .
HUMAN MOLECULAR GENETICS, 1994, 3 (12) :2263-2263
[8]   DELETION POLYMORPHISM IN THE GENE FOR ANGIOTENSIN-CONVERTING ENZYME IS A POTENT RISK FACTOR FOR MYOCARDIAL-INFARCTION [J].
CAMBIEN, F ;
POIRIER, O ;
LECERF, L ;
EVANS, A ;
CAMBOU, JP ;
ARVEILER, D ;
LUC, G ;
BARD, JM ;
BARA, L ;
RICARD, S ;
TIRET, L ;
AMOUYEL, P ;
ALHENCGELAS, F ;
SOUBRIER, F .
NATURE, 1992, 359 (6396) :641-644
[9]  
CECCHERINI I, 1994, ONCOGENE, V9, P3025
[10]   INFLUENCE OF AGE AND SEX ON PLASMA CALCITONIN IN HUMAN-BEINGS [J].
DEFTOS, LJ ;
WEISMAN, MH ;
WILLIAMS, GW ;
KARPF, DB ;
FRUMAR, AM ;
DAVIDSON, BJ ;
PARTHEMORE, JG ;
JUDD, HL .
NEW ENGLAND JOURNAL OF MEDICINE, 1980, 302 (24) :1351-1353